Aeglea BioTherapeutics
mobility assessments capture potential clinical benefit of in phase trial a sunes | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
34 of 39
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
May 2023
mobility assessments capture potential clinical benefit of in phase trial wees a a | Aeglea BioTherapeutics
Investor Presentation
April 2023
mobility assessments capture potential clinical benefit of in phase trial wees a a | Aeglea BioTherapeutics
Related slides by other companies
MindMed
Investor Presentation
November 2024
phase gad part a trials primary key secondary voyage panorama | MindMed
MindMed
Investor Presentation
December 2024
phase gad part a trials primary key secondary | MindMed
Oculis
Investor Conference
June 2023
next step phase trial stage | Oculis
ATAI
Investor Day
January 2022
change from in the overall composite score | ATAI
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights